Annual EBIT
-$114.65 M
-$57.56 M-100.83%
31 December 2023
Summary:
Poseida Therapeutics annual earnings before interest & taxes is currently -$114.65 million, with the most recent change of -$57.56 million (-100.83%) on 31 December 2023. During the last 3 years, it has risen by +$11.62 million (+9.20%). PSTX annual EBIT is now -484.04% below its all-time high of -$18.95 million.PSTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$22.57 M
+$51.69 M+177.54%
30 September 2024
Summary:
Poseida Therapeutics quarterly earnings before interest & taxes is currently $22.57 million, with the most recent change of +$51.69 million (+177.54%) on 30 September 2024. Over the past year, it has increased by +$52.01 million (+176.69%). PSTX quarterly EBIT is now -68.84% below its all-time high of $72.44 million, reached on 30 September 2022.PSTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$51.64 M
+$52.01 M+50.18%
30 September 2024
Summary:
Poseida Therapeutics TTM earnings before interest & taxes is currently -$51.64 million, with the most recent change of +$52.01 million (+50.18%) on 30 September 2024. Over the past year, it has increased by +$70.98 million (+57.88%). PSTX TTM EBIT is now -311.85% below its all-time high of -$12.54 million, reached on 31 March 2019.PSTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.8% | +176.7% | +57.9% |
| 3 y3 years | +9.2% | +154.3% | +67.6% |
| 5 y5 years | -167.8% | +212.8% | +14.3% |
PSTX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.8% | +9.2% | -68.8% | +139.6% | -148.9% | +67.6% |
| 5 y | 5 years | -167.8% | +9.2% | -68.8% | +139.6% | -148.9% | +67.6% |
| alltime | all time | -484.0% | +9.2% | -68.8% | +139.6% | -311.9% | +67.6% |
Poseida Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $22.57 M(-177.5%) | -$51.64 M(-50.2%) |
| June 2024 | - | -$29.11 M(+32.2%) | -$103.65 M(+3.8%) |
| Mar 2024 | - | -$22.02 M(-4.6%) | -$99.85 M(-12.9%) |
| Dec 2023 | -$114.65 M(+100.8%) | -$23.08 M(-21.6%) | -$114.65 M(-6.5%) |
| Sept 2023 | - | -$29.43 M(+16.3%) | -$122.62 M(+491.0%) |
| June 2023 | - | -$25.32 M(-31.2%) | -$20.75 M(-43.8%) |
| Mar 2023 | - | -$36.82 M(+18.6%) | -$36.93 M(-35.3%) |
| Dec 2022 | -$57.09 M(-53.1%) | -$31.05 M(-142.9%) | -$57.09 M(+140.6%) |
| Sept 2022 | - | $72.44 M(-274.6%) | -$23.73 M(-82.8%) |
| June 2022 | - | -$41.49 M(-27.2%) | -$137.75 M(-2.4%) |
| Mar 2022 | - | -$56.98 M(-2567.7%) | -$141.12 M(+16.0%) |
| Dec 2021 | -$121.62 M | $2.31 M(-105.6%) | -$121.62 M(-23.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$41.59 M(-7.3%) | -$159.22 M(+5.3%) |
| June 2021 | - | -$44.86 M(+19.7%) | -$151.20 M(+11.3%) |
| Mar 2021 | - | -$37.48 M(+6.2%) | -$135.87 M(+7.6%) |
| Dec 2020 | -$126.27 M(+52.2%) | -$35.30 M(+5.2%) | -$126.27 M(+11.1%) |
| Sept 2020 | - | -$33.57 M(+13.6%) | -$113.67 M(+13.5%) |
| June 2020 | - | -$29.54 M(+6.0%) | -$100.12 M(+1.8%) |
| Mar 2020 | - | -$27.87 M(+22.8%) | -$98.31 M(+18.5%) |
| Dec 2019 | -$82.97 M(+93.8%) | -$22.69 M(+13.4%) | -$82.97 M(+37.6%) |
| Sept 2019 | - | -$20.02 M(-27.8%) | -$60.28 M(+49.7%) |
| June 2019 | - | -$27.72 M(+121.1%) | -$40.26 M(+221.1%) |
| Mar 2019 | - | -$12.54 M | -$12.54 M |
| Dec 2018 | -$42.81 M(+118.1%) | - | - |
| Dec 2017 | -$19.63 M | - | - |
FAQ
- What is Poseida Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Poseida Therapeutics?
- What is Poseida Therapeutics annual EBIT year-on-year change?
- What is Poseida Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Poseida Therapeutics?
- What is Poseida Therapeutics quarterly EBIT year-on-year change?
- What is Poseida Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Poseida Therapeutics?
- What is Poseida Therapeutics TTM EBIT year-on-year change?
What is Poseida Therapeutics annual earnings before interest & taxes?
The current annual EBIT of PSTX is -$114.65 M
What is the all time high annual EBIT for Poseida Therapeutics?
Poseida Therapeutics all-time high annual earnings before interest & taxes is -$18.95 M
What is Poseida Therapeutics annual EBIT year-on-year change?
Over the past year, PSTX annual earnings before interest & taxes has changed by -$57.56 M (-100.83%)
What is Poseida Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of PSTX is $22.57 M
What is the all time high quarterly EBIT for Poseida Therapeutics?
Poseida Therapeutics all-time high quarterly earnings before interest & taxes is $72.44 M
What is Poseida Therapeutics quarterly EBIT year-on-year change?
Over the past year, PSTX quarterly earnings before interest & taxes has changed by +$52.01 M (+176.69%)
What is Poseida Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of PSTX is -$51.64 M
What is the all time high TTM EBIT for Poseida Therapeutics?
Poseida Therapeutics all-time high TTM earnings before interest & taxes is -$12.54 M
What is Poseida Therapeutics TTM EBIT year-on-year change?
Over the past year, PSTX TTM earnings before interest & taxes has changed by +$70.98 M (+57.88%)